Literature DB >> 12749424

Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle.

James R Stelling1, Emily T Chapman, David Frankfurter, Doria H Harris, Selwyn P Oskowitz, Richard H Reindollar.   

Abstract

OBJECTIVE: To confirm that hCG levels in follicular fluid and serum would be comparable between i.m. and s.c. administration of purified hCG.
DESIGN: In a prospective study, serum and follicular fluid levels of hCG after an i.m. or s.c. injection of 10,000 IU of hCG were evaluated 36 hours after injection, that is, at the time of oocyte retrieval.
SETTING: This study was carried out in a university-affiliated IVF program. PATIENT(S): Forty women undergoing oocyte retrieval were entered into the study at the time of egg retrieval, that is, 36 hours after hCG administration. INTERVENTION(S): S.c. or i.m. injection of hCG. MAIN OUTCOME MEASURE(S): Serum and follicular fluid concentrations of hCG were evaluated 36 hours after injection at the time of oocyte retrieval. RESULT(S): There was a significantly higher serum hCG level in the s.c. group (348.6 +/- 98 IU/L) vs. the i.m. group (259.0 +/- 115 IU/L) and a significantly higher follicular fluid hCG level in the s.c. vs. the i.m. group (233.5 +/- 85 vs. 143.4 +/- 134 IU/L). CONCLUSION(S): After purified hCG administration via the s.c. route, both serum and follicular fluid levels are greater compared with the i.m. route.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749424     DOI: 10.1016/s0015-0282(02)04918-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Human chorionic gonadotropin (hCG) plasma levels at oocyte retrieval and IVF outcomes.

Authors:  R Matorras; A Meabe; R Mendoza; B Prieto; O Ramón; J Mugica; F Aspichueta; A Exposito
Journal:  J Assist Reprod Genet       Date:  2012-07-20       Impact factor: 3.412

2.  Human chorionic gonadotropin serum levels following ovulation triggering and IVF cycle outcome.

Authors:  Yossi Mizrachi; Eran Horowitz; Jacob Farhi; David Levran; Arieh Raziel; Ariel Weissman
Journal:  J Assist Reprod Genet       Date:  2018-03-23       Impact factor: 3.412

3.  Pharmacokinetics of human chorionic gonadotropin injection in obese and normal-weight women.

Authors:  Divya K Shah; Stacey A Missmer; Katharine F B Correia; Elizabeth S Ginsburg
Journal:  J Clin Endocrinol Metab       Date:  2014-01-29       Impact factor: 5.958

Review 4.  The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection.

Authors:  Jing-Fen Jin; Ling-Ling Zhu; Meng Chen; Hui-Min Xu; Hua-Fen Wang; Xiu-Qin Feng; Xiu-Ping Zhu; Quan Zhou
Journal:  Patient Prefer Adherence       Date:  2015-07-02       Impact factor: 2.711

5.  Randomized Pharmacokinetic Study of a Highly Purified Human Chorionic Gonadotropin and of a Recombinant Human Chorionic Gonadotropin Following Single Subcutaneous Administration in Healthy Women.

Authors:  Milko Radicioni; Chiara Leuratti; Barbara Cometti
Journal:  Clin Drug Investig       Date:  2022-02-09       Impact factor: 2.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.